Moleculin Announces Collaboration with Emory University to Develop Novel Treatment of Pediatric Brain Cancer Feb 13, 2018
Moleculin Expands Leukemia Development Portfolio with Immuno-Stimulating STAT3 Inhibitor Jan 10, 2018
Moleculin to Present at the 10th Annual LD Micro Main Event on December 5, 2017 at 11:30 a.m. PT Nov 21, 2017
Moleculin Biotech, Inc. Reports Financial Results for the Third Quarter Ended September 30, 2017 Nov 14, 2017